Abstract A015: A prospective cohort study of biological aging and epigenetic age acceleration in 106 patients with age and therapy-related clonal hematopoiesis
Marissa Li(APLA Health), Mrinal M. Patnaik(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic), Jenna Fernandez(Mayo Clinic), James M. Foran(Memorial Sloan Kettering Cancer Center), Kristina Kirschner(Mayo Clinic), Yael Kusne(WinnMed), Tamir Chandra(Mayo Clinic in Arizona), Alejandro Ferrer(Mayo Clinic), Kristen McCullough(Mayo Clinic), Christy M. Finke(Mayo Clinic), Talha Badar(Mayo Clinic in Florida), Sarah Aug(Mayo Clinic), Rachel Simon(Mayo Clinic in Arizona), Naseema Gangat(Mayo Clinic in Arizona), Terra Lasho(Toyota Motor Corporation (Switzerland)), Cecilia Y. Arana Yi(Mayo Clinic in Arizona)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540